Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Long-term clinical outcomes from the smart start trial: rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma.
Journal: Blood cancer journal
Published: January 27, 2026
Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy.
Journal: Blood cancer journal
Published: July 07, 2025
Phase I study of pomalidomide in relapsed or refractory Waldenström macroglobulinaemia.
Journal: British journal of haematology
Published: April 09, 2025
The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events.
Journal: Leukemia
Published: July 01, 2024
Clinical implications of frailty assessed in hospitalized patients with acute-exacerbation of interstitial lung disease.
Journal: Chronic respiratory disease
Published: March 22, 2024
Novel Approaches to Managing Patients with Relapsed and Refractory Waldenström Macroglobulinemia.
Journal: Current hematologic malignancy reports
Published: February 26, 2024
Real-world associations of cytokine release syndrome and neurotoxicity with efficacy in patients receiving anti-CD-19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: the Mayo Clinic experience.
Journal: Leukemia & lymphoma
Published: November 30, 2023
BRAT1-Associated Leukodystrophy Exacerbated by Classic Hodgkin Lymphoma-Directed Therapy.
Journal: The neurologist
Published: November 29, 2023
MicroRNA and long non-coding RNA analysis in IgM-monoclonal gammopathies reveals epigenetic influence on cellular functions and oncogenesis.
Journal: Haematologica
Published: July 13, 2023
Last Updated: 09/26/2026